Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
576
Banco Santander Chile
BSAC
$15.2B
| $32M | 0.03% |
1,954,000
+132,400
| +7% | +$2.18M |
2015 Q3
19 quarters
|
|
577
Fortuna Silver Mines
FSM
$3.23B
| $32M | 0.03% |
6,285,931
-1,104,200
| -15% | -$3.99M |
2017 Q2
12 quarters
|
|
|
NVRO
578
DELISTED
NEVRO CORP.
NVRO
| $31.9M | 0.03% |
267,400
-126,217
| -32% | -$15M |
2019 Q4
2 quarters
|
|
579
Mid-America Apartment Communities
MAA
$13.6B
| $31.9M | 0.03% |
278,449
-46,225
| -14% | -$5.21M |
2014 Q3
23 quarters
|
|
580
Berkshire Hathaway Class B
BRK.B
$1.1T
| $31.7M | 0.03% |
177,665
+109,977
| +162% | +$20.1M |
2020 Q1
1 quarter
|
|
581
Avantor
AVTR
$10.6B
| $31.7M | 0.03% |
+1,865,200
| New | +$30.4M |
2020 Q2
0 quarters
|
|
582
Steris
STE
$20.9B
| $31.6M | 0.03% |
205,700
+161,410
| +364% | +$24.6M |
2019 Q3
3 quarters
|
|
583
Axalta
AXTA
$6.98B
| $31.5M | 0.03% |
1,398,277
-1,433,100
| -51% | -$29.3M |
2016 Q1
17 quarters
|
|
584
Anika Therapeutics
ANIK
$262M
| $31.5M | 0.03% |
834,917
+87,088
| +12% | +$2.87M |
2013 Q2
28 quarters
|
|
|
ALX
585
Alexander's
ALX
$1.23B
| $31.5M | 0.03% |
130,614
+400
| +0.3% | +$107K |
2013 Q2
28 quarters
|
|
586
Intuit
INTU
$80.9B
| $31.4M | 0.03% |
+105,960
| New | +$29.1M |
2020 Q2
0 quarters
|
|
587
Teladoc Health
TDOC
$1.05B
| $31.3M | 0.03% |
164,200
+115,320
| +236% | +$20.2M |
2019 Q4
2 quarters
|
|
588
Exponent
EXPO
$3.32B
| $31.3M | 0.03% |
386,900
-135,900
| -26% | -$9.78M |
2013 Q2
28 quarters
|
|
589
International Flavors & Fragrances
IFF
$21.6B
| $31.2M | 0.03% |
+255,000
| New | +$32.2M |
2020 Q2
0 quarters
|
|
590
Warrior Met Coal
HCC
$4.91B
| $31.2M | 0.03% |
2,028,479
-437,200
| -18% | -$5.96M |
2018 Q3
7 quarters
|
|
|
LBRDK
591
DELISTED
Liberty Broadband Class C
LBRDK
| $31.2M | 0.03% |
251,700
-5,300
| -2% | -$665K |
2019 Q4
2 quarters
|
|
592
Johnson Outdoors
JOUT
$448M
| $31M | 0.03% |
340,600
-12,700
| -4% | -$908K |
2013 Q2
28 quarters
|
|
|
ATRI
593
DELISTED
Atrion Corp
ATRI
| $31M | 0.03% |
48,600
-100
| -0.2% | -$65.4K |
2013 Q2
28 quarters
|
|
594
First Majestic Silver
AG
$8.52B
| $30.8M | 0.03% |
3,098,600
-1,755,438
| -36% | -$14.9M |
2019 Q3
3 quarters
|
|
595
Forrester Research
FORR
$217M
| $30.7M | 0.03% |
959,424
-30,582
| -3% | -$971K |
2013 Q2
28 quarters
|
|
|
SPTN
596
DELISTED
SpartanNash
SPTN
| $30.7M | 0.03% |
1,445,478
+729,366
| +102% | +$13.1M |
2018 Q2
8 quarters
|
|
597
Roper Technologies
ROP
$36B
| $30.7M | 0.03% |
+79,100
| New | +$28.3M |
2020 Q2
0 quarters
|
|
598
Stepan Co
SCL
$1.39B
| $30.7M | 0.03% |
316,100
-54,800
| -15% | -$5.15M |
2013 Q2
28 quarters
|
|
|
CTT
599
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $30.7M | 0.03% |
3,464,067
-89,100
| -3% | -$690K |
2015 Q2
20 quarters
|
|
600
Autohome
ATHM
$2.38B
| $30.7M | 0.03% |
406,018
+346,418
| +581% | +$27.1M |
2019 Q2
4 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.